Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details)

v3.24.1.1.u2
Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 19, 2022
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2024
Nov. 25, 2020
Subscription receivable     $ 204,000 $ 14,104,000  
Represents information pertaining to RubrYc Therapeutics, Inc.          
Sale of preferred stock $ 1,000,000        
Number of shares issued 5,117        
Sales Agreement | Cantor Fitzgerald [Member]          
Aggregate offering price         $ 100,000,000
Number of shares issued   170,989 289,143    
Proceeds from sale of shares, net of issuance cost   $ 1,700,000 $ 6,400,000    
Subscription receivable     $ 204,000